...
Dataset wrap |
---|
|
Rowcaps |
---|
Rows 1-2: | I examined the TTE image of the heart (test location) and found calcified mitral valve annulus (result location). |
---|
Rows 3-4: | I examined the TTE image of the heart (test location) and found that the mitral valve (result location) had become stenotic. |
---|
Rows 5-6: | I examined the TTE image of the heart (test location) and regurgitation of blood in the mitral valve back into the left atrium. |
---|
|
Dataset2 |
---|
hi1style | aqua |
---|
hi1 | 2,4,6 |
---|
tableid | TU1 |
---|
|
Row | STUDYID | DOMAIN | USUBJID | TUSEQ | TUGRPID | TULNKID | TUTEST | TULOC | TUORRES | TURESLOC | TULOCTURESLOC Detail | TUMETHOD | VISITNUM | VISIT | TUDTC | TURESLOC | TURESLOC Detail |
---|
1 | ABC | TU | ABC-456 | 1 | 1 | CAL 1 | Calcification Indicator | HEART | YHEART |
|
| TRANSTHORACIC ECHOCARDIOGRAPHY | 1 | BASELINE | 2020-04-27 |
---|
2 | ABC | TU | ABC-456 | 2 | 1 | CAL 1 | Calcification Location Identification | Located | HEART | identified | Mitral Valve AnnulusHEART |
| TRANSTHORACIC ECHOCARDIOGRAPHY | 1 | BASELINE | 2020-04-27 | Mitral Valve Annulus |
---|
3 | ABC | TU | ABC-456 | 3 | 2 | STEN 1 | Cardiac Valvular Stenosis Indicator | HEART | Y | HEART |
|
| TRANSTHORACIC ECHOCARDIOGRAPHY | 1 | BASELINE | 2020-04-27 |
---|
4 | ABC | TU | ABC-456 | 4 | 2 | STEN 1 | Cardiac Valvular Stenosis Location Identification | HEART | Locatedidentified | HEARTMitral Valve |
| TRANSTHORACIC ECHOCARDIOGRAPHY | 1 | BASELINE | 2020-04-27 | Mitral Valve |
---|
5 | ABC | TU | ABC-456 | 5 | 3 | REGUR 1 | Cardiac Valvular Regurgitation Indicator | HEART | YHEART |
|
| TRANSTHORACIC ECHOCARDIOGRAPHY | 1 | BASELINE | 2020-04-27 |
---|
6 | ABC | TU | ABC-456 | 6 | 3 | REGUR 1 | Cardiac Valvular Regurgitation Location Identification | Located | | HEART | identified | Mitral Valve | Into the left atriumHEART | TRANSTHORACIC ECHOCARDIOGRAPHY | 1 | BASELINE | 2020-04-27 | Mitral Valve | Into the left atrium |
---|
|
|
Note these tests were originally created as a CVTEST, based on CVTESTs, if users are using SDTMIG version prior to 3.4. Per SDTMIG 3.4, this is now considered as a grading scale and therefore should now be represented as CC/RS. Note the RSTEST still takes the original CV domain terminology naming convention, it does not comply with QRS rules.
Dataset wrap |
---|
|
Rowcaps |
---|
Row 1: | Mitral valve stenosis is moderate. |
---|
Row 2: | Mitral valve regurgitation is severe. |
---|
|
Dataset2 |
---|
Row | STUDYID | DOMAIN | USUBJID | RSSEQ | RSLNKID | RSTEST | RSCAT | RSORRES | VISITNUM | VISIT | RSDTC |
---|
1 | ABC | RS(CC) | ABC-456 | 1 | REGUR 1 | VSC-Cardiac Valvular Stenosis Severity |
---|
Baumgartner Valve Stenosis 2009VALVE STENOSIS CLASSIFICATION 2009 VERSION | Moderate | 1 | BASELINE | 2020-04-27 | 2 | ABC | RS(CC) | ABC-456 | 2 | STEN 1 | SNVRC-Cardiac Valvular Regurgitation Severity |
---|
Zoghbi Severity of Native Valvular Regurgitation SEVERITY OF NATIVE VALVULAR REGURGITATION CLASSIFICATION 2003 | Severe | 1 | BASELINE | 2020-04-27 |
|
|
The below example shows how to represent calcification severity from a sponsor defined criteria using the CV TR domain. The Mitral Valve Annulus identified in TU is severely calcified.
Jordan: i originally mapped this to CV but this is an assessment of lesion severity, thusly can be considered as lesion properties? So I changed this dataset to TR instead. I seriously wonder whose idea it was to create a separate non-tumor lesion domain when everything on this page could have been mapped to the single CV domain (except the peer-reviewed, published clinical classifications). How do you expect users to know these details by just reading the SDTMIG?
dataset-wrap |
---|
|
Dataset2 |
---|
Row | STUDYID | DOMAIN | USUBJID | RSSEQ | CVLNKIDTRLNKID | CVTESTTRTEST | CVCATTRCAT | CVORRESTRORRES | CVMETHODTRMETHOD | VISITNUM | VISIT | RSDTC |
---|
1 | ABC | CVTR | ABC-456 | 1 | CAL 1 | Calcification Severity | Sponsor-defined Criteria | Severe | TTE | 1 | BASELINE | 2020-04-27 |
---|
|
|
...